These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 8531077
1. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes. Magnon M, Gallix P, Cavero I. J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077 [Abstract] [Full Text] [Related]
2. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles. Nishimura K, Miyawaki N, Yamauchi H, Iso T. Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000 [Abstract] [Full Text] [Related]
3. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R. Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [Abstract] [Full Text] [Related]
4. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies. Polster P, Christophe B, Van Damme M, Houlliche A, Chatelain P. J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816 [Abstract] [Full Text] [Related]
6. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Sarsero D, Fujiwara T, Molenaar P, Angus JA. Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350 [Abstract] [Full Text] [Related]
7. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium. Saïag B, Milon D, Bentue-Ferrer D, Allain H, Rault B, Van den Driessche J. Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975 [Abstract] [Full Text] [Related]
12. Evidence for the possible involvement of Ca2+ entry blockade in the relaxation by class I antiarrhythmic drugs in the isolated pig coronary smooth muscle. Tanaka Y, Kamibayashi M, Yamashita Y, Imai T, Tanaka H, Nakahara T, Ishii K, Shigenobu K. Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):56-66. PubMed ID: 11862334 [Abstract] [Full Text] [Related]
13. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries. Godfraind T, Miller RC. Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654 [Abstract] [Full Text] [Related]
15. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H, Hashizume M, Masuda Y, Fujitani B, Hosoki K. Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [Abstract] [Full Text] [Related]
16. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile. Fleckenstein A, Frey M, Zorn J, Fleckenstein-Grün G. Am J Cardiol; 1989 Nov 07; 64(17):21I-34I. PubMed ID: 2530884 [Abstract] [Full Text] [Related]